Introduction:

the prostate cancer is the first cause of death for cancer in the Cuban men and it affects the sexual quality of life.

Objective:

to characterize the results of the use of the sildenafil for the management of the erectile sexual dysfunction in patient with prostate cancer tried with hormones or radiotherapy.

Method:

was an observational, ambispective and traverse study, in the Service of Urology of the Hospital Dr. Agostinho Neto of Guantánamo during the period 2014-2018 that it was approved by the committee of medical ethics. The study universe conformed to for 70 patients with diagnostic of prostate cancer, treaties with hormones and/or radiotherapy, and that they presented erectile dysfunction. In each patient was studied the age, treatment that was applied for the cancer, time of appearance of the dysfunction after this, and the answer of the erectile function of the penis to the sildenafil use.

Results:

The 37.2% of the patients had between 70 and 79 years of age and 79.1% were talked with hormones. The biggest proportion presented erectile dysfunction 1 to 2 years after the treatment (48.8%). The 81.4% responded appropriately to the treatment with sildenafil, what was independent of the treatment of the cancer with hormones or radiotherapy.

Conclusion:

The patients with prostate cancer tried with hormones and/or radiotherapy benefitted with the use of the sildenafil.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )